Home › NAVINFLUOR › Filing
🔔 Get instant alerts when NAVINFLUOR files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 30 Oct 2026, 16:01 IST Exchange: NSE Category: Financial Results — Investor Presentation
AI summary - H1 FY27 consolidated sales Rs 2,235.8 Cr, +51% YoY; Operating EBITDA margin 34.19%, +367 bps YoY - Q2 FY27 sales Rs 1,190.7 Cr, +57% YoY, +14% QoQ; Operating EBITDA margin 34.22%, +176 bps YoY - Specialty Chemicals revenue +58% YoY; CDMO revenue +78% YoY with Rs 125 Cr capex by Q4 FY27 - Capex of Rs 236.5 Cr for additional HFC capacity (15,000 MTPA R32) commissioning shortly - Strong order visibility, product pipeline scaling, and extended HFO supply contract with $590M value - ESG focus: 30% carbon emission reduction by 2030, 50% renewable electricity use by 2030 - Board highly engaged with 8 meetings in FY26 and strong governance framework
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 NAVINFLUOR — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add NAVINFLUOR to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Navin Fluorine International Limited

Important. The summary above is generated automatically from Navin Fluorine International Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.